SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601364-15-000001
Filing Date
2015-01-26
Accepted
2015-01-26 16:59:59
Documents
1
Period of Report
2015-01-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7222
  Complete submission text file 0001601364-15-000001.txt   9204
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Issuer) CIK: 0001513818 (see all company filings)

IRS No.: 244106690 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences Fund I LP (Reporting) CIK: 0001601363 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 15549185

Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences LLP (Reporting) CIK: 0001601364 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 15549186